These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17067603)

  • 1. Effects of iron and HFE mutations on response to therapy in chronic hepatitis C: an ironic interaction?
    Alexander J; Kowdley KV
    Gastroenterology; 2006 Nov; 131(5):1635-8. PubMed ID: 17067603
    [No Abstract]   [Full Text] [Related]  

  • 2. HFE gene mutations prevent sustained virological response to interferon plus ribavirin in chronic hepatitis C patients with serum markers of iron overload.
    Coelho-Borges S; Cheinquer H; Cheinquer N; Krug L; Ashton-Prolla P
    Am J Gastroenterol; 2002 Jun; 97(6):1570-2. PubMed ID: 12094895
    [No Abstract]   [Full Text] [Related]  

  • 3. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
    Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
    Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron overload and chronic hepatitis C: the role of HFE gene mutations.
    García Buey L; González Mateos F
    Rev Esp Enferm Dig; 2003 Dec; 95(12):819-28. PubMed ID: 14972003
    [No Abstract]   [Full Text] [Related]  

  • 5. [Iron as comorbid factor in chronic hepatitis C].
    Erhardt A; Hauck K; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):685-91. PubMed ID: 14685669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemosiderosis in Chronic Hepatitis C: Should Venesection Precede Treatment with Interferon-alpha and Ribavirin?].
    Bauditz J; Roske AE; Schmidt HH
    Z Gastroenterol; 2004 Feb; 42(2):167-70. PubMed ID: 14963790
    [No Abstract]   [Full Text] [Related]  

  • 7. Iron, the HFE gene, and hepatitis C.
    Eisenbach C; Gehrke SG; Stremmel W
    Clin Liver Dis; 2004 Nov; 8(4):775-85, vii-viii. PubMed ID: 15464655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C, iron, and hemochromatosis gene mutations. A meaningful relationship or simple cohabitation?
    Snover DC
    Am J Clin Pathol; 2000 Apr; 113(4):475-8. PubMed ID: 10761447
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of some hepatic immunological markers, iron load and virus genotype in chronic hepatitis C.
    Cardoso EM; Duarte MA; Ribeiro E; Rodrigues P; Hultcrantz R; Sampaio P; Ehrlich R; Carvalho J; Fraga J; de Sousa M
    J Hepatol; 2004 Aug; 41(2):319-26. PubMed ID: 15288483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations.
    Pirisi M; Scott CA; Avellini C; Toniutto P; Fabris C; Soardo G; Beltrami CA; Bartoli E
    Am J Clin Pathol; 2000 Apr; 113(4):546-54. PubMed ID: 10761457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
    Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
    Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
    Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
    Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
    Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
    Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course.
    Corengia C; Galimberti S; Bovo G; Vergani A; Arosio C; Mariani R; Redaelli A; Riva A; Cestari C; Pozzi M; Valsecchi MG; Piperno A
    Am J Clin Pathol; 2005 Dec; 124(6):846-53. PubMed ID: 16416733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-transferrin-bound iron in untreated and ribavirin-treated chronic hepatitis C patients.
    Van Vlierberghe H; Verdievel H; Colle I; Delanghe J; Praet M; Bernard D; Leroux-Roels G; De Vos M
    Aliment Pharmacol Ther; 2002 Aug; 16(8):1555-62. PubMed ID: 12182756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
    Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
    Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heterozygosis H63D in patients with steatohepatitis and chronic hepatitis C].
    Pulvirenti D; Neri S; Bertino G; Cutuli N; Ignaccolo L; Misseri M; Tsami A; Caruso L
    Clin Ter; 2006; 157(6):485-8. PubMed ID: 17228846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.
    Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS
    Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.